GlassScriptPhysician profile
Zane K Basrawala
NPI 1902839780
$9,761.39
in general payments reported to CMS, 2019-2025
56 companies · $1,699 in 2025
The $1,699 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $745 · 2021: $1,643 · 2022: $1,520 · 2023: $1,890 · 2024: $1,642 · 2025: $1,699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,225 · Education: $5.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,224.53 |
| Education | $5.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,181.67 | 2021-2025 | Interstim |
| Astellas Pharma US INC | $873.14 | 2019-2024 | Myrbetriq, Veozah, Xtandi |
| Boston Scientific Corporation | $705.91 | 2019-2025 | Lithovue, General - Erectile Dysfunction, Axonics |
| Urogen Pharma, INC. | $576.96 | 2020-2025 | Jelmyto |
| Sumitomo Pharma America, INC. | $466.07 | 2023-2025 | Orgovyx, Gemtesa |
| Endo Pharmaceuticals INC. | $455.16 | 2019-2024 | Xiaflex, Aveed |
| Abbvie INC. | $372.21 | 2019-2025 | Lupron Depot |
| Procept Biorobotics Corporation | $331.26 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Dendreon Pharmaceuticals LLC | $318.23 | 2019-2025 | Provenge |
| Coloplast Corp | $266.19 | 2021-2025 | Speedicath, Titan |
| Ethicon US, LLC | $259.28 | 2019-2022 | |
| Calyxo, INC. | $248.08 | 2025 | Cvac Aspiration System |
| Pfizer INC. | $242.48 | 2019-2025 | |
| Axogen | $233.06 | 2024-2025 | Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Axonics, INC. | $228.63 | 2021-2023 | Axonics |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zane Basrawala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.